Two-Year Real-World Outcomes in Women with Genitourinary Syndrome of Menopause Following Fractional CO2 Laser Treatment
International Urogynecology Journal · 2026-10 · 37 (10) · 3233-3240
DOI: 10.1007/s00192-026-06687-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urogynecology Journal, online erschienen am 16.05.2026. Verfasst von Telal Dogruel und 5 weiteren Autor:innen. Beteiligte Einrichtung: VM Medical Park Maltepe Hospital Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Istanbul, Turke…. Hauptthemen laut MEDLINE: Lasers, Gas, Female Urogenital Diseases. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: To evaluate the short- and long-term clinical outcomes of fractional CO2 laser therapy in postmenopausal women with genitourinary syndrome of menopause (GSM), including durability of symptom control and the need for booster sessions. METHODS: This retrospective single-center study included 126 postmenopausal women with GSM who underwent a standardized three-session fractional CO2 laser protocol. Booster sessions were applied in cases of symptom recurrence. Outcomes were assessed at baseline, 4-6 weeks, 1 year, and 2 years using validated instruments: Patient Satisfaction Score, Michigan Incontinence Severity Index (MISI), Female Sexual Function Index (FSFI) and its subdomains, Vulvovaginal Symptoms Questionnaire (VSQ), and Female Genital Self-Image Scale (FGSIS). RESULTS: Significant improvement was observed in all outcome measures at 4-6 weeks, including GSM-related symptoms, sexual function, and genital self-image (all p < 0.0001). These benefits were largely sustained at 1 year. Although a slight decline was noted at 2 years, scores remained significantly improved compared to baseline. For example, FSFI lubrication scores improved from 2.97 ± 0.55 at baseline to 4.54 ± 0.49 at 1 year, and both VSQ and FGSIS demonstrated persistent gains at 2 years. Satisfaction scores continued to increase over time. Post hoc analyses confirmed significant differences across all evaluation time points. CONCLUSION: Fractional CO2 laser therapy provides clinically meaningful and durable improvement in GSM-related symptoms in postmenopausal women. While some decline may occur over time, benefits remain superior to baseline, and booster sessions may support long-term maintenance. Fractional CO2 laser may represent a nonhormonal, symptom-oriented option for carefully selected patients with GSM; however, it should not be considered first-line therapy, and prospective controlled studies are needed to further define long-term efficacy and patient selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VM Medical Park Maltepe Hospital Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Istanbul, Turkey.
- Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Women's Health Clinic, Istanbul, Turkey. pinarsezer33@hotmail.com.
- Department of Plastic, Reconstructive and Aesthetic Surgery, Prof. Dr. Süleyman Yalçın City Hospital, Istanbul, Turkey.
- Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Acıbadem Kayseri Hospital, Istanbul, Turkey.
- Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Women's Health Clinic, Istanbul, Turkey.
- Department of Obstetrics and Gynecology, Women's Health Clinic, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), İstanbul Nişantası University, Istanbul, Turkey.
Zitieren
APA
Dogruel, T., Kadirogullari, P., Dogruel, H. C., Dogan, U. K., Comert, E. H., & Dogan, O. (2026). Two-Year Real-World Outcomes in Women with Genitourinary Syndrome of Menopause Following Fractional CO2 Laser Treatment. International Urogynecology Journal, 37(10), 3233-3240. https://doi.org/10.1007/s00192-026-06687-4
Vancouver
Dogruel T, Kadirogullari P, Dogruel HC, Dogan UK, Comert EH, Dogan O. Two-Year Real-World Outcomes in Women with Genitourinary Syndrome of Menopause Following Fractional CO2 Laser Treatment. International Urogynecology Journal. 2026;37(10):3233-3240. doi:10.1007/s00192-026-06687-4
BibTeX
@article{Dogruel2026,
author = {Dogruel, Telal and Kadirogullari, Pinar and Dogruel, Hikmet Can and Dogan, Umran Karabulut and Comert, Erhan Huseyin and Dogan, Ozan},
title = {Two-Year Real-World Outcomes in Women with Genitourinary Syndrome of Menopause Following Fractional CO2 Laser Treatment},
journal = {International Urogynecology Journal},
year = {2026},
volume = {37},
number = {10},
pages = {3233--3240},
doi = {10.1007/s00192-026-06687-4}
}
EUVIMED